Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Uveal Melanoma 6Melanoma 5Select Advanced Solid Tumors 1Sarcoma, Clear Cell 1Sarcoma 1Nevus, Blue 1Neoplasm Metastasis 1Diabetes Mellitus, Insulin-Dependent, 12 1Advanced or Metastatic Solid Tumors 1

Interventions

Doxorubicin 141Ifosfamide 85Radiotherapy 80Cyclophosphamide 72Gemcitabine 63Filgrastim 54pembrolizumab 43pazopanib 39Etoposide 39Docetaxel 39Vincristine 37Cisplatin 35Trabectedin 32Nivolumab 32Irinotecan 26Magnetic Resonance Spectroscopy 25Carboplatin 25Temozolomide 23Ipilimumab 22Bevacizumab 20Radiation 19Granulocyte Colony-Stimulating Factor 18Surgical Procedures, Operative 17Sirolimus 17Mesna 17Melphalan 17Dactinomycin 17Biopsy 17eribulin 16Specimen Handling 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Sarcoma × tebentafusp × Clear all
NCT06942442 2025-12-26

A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma

Sarcoma Alliance for Research through Collaboration

Phase 2 Recruiting
47 enrolled
Sarcoma

Sarcoma, Sarcoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡